galactarate transmembrane transport

description: The process in which galactaric acid anion (galactarate) is transported across a lipid bilayer, from one side of a membrane to the other.


GTP synthesis coupled proton transport

category: biolink:BiologicalProcess biolink:Occurrent biolink:OntologyClass biolink:BiologicalProcessOrActivity biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing biolink:PhysicalEssenceOrOccurrent

description: The transport of protons across a membrane to generate an electrochemical gradient (proton-motive force) that powers GTP synthesis.


micropinocytosis

description: An endocytosis process that results in the uptake of liquid material by cells from their external environment by invagination of the plasma membrane to form uncoated micropinosomes, differentiated from macropinosomes by their smaller size, on average 95 nm.


salicin transport

description: The directed movement of salicin (saligenin-beta-D-glucopyranoside), a glucoside of o-hydroxybenzylalcohol, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.


name: L-histidine transmembrane import into vacuole

description: The directed movement of L-histidine into the vacuole across the vacuolar membrane.


nucleotide-sulfate transport

description: The directed movement of nucleotide sulfate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.


2-aminoethylphosphonate transport

description: The directed movement of 2-aminoethylphosphonate, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.


name: negative regulation of signal transduction by receptor internalization

description: Any process in which internalization of a signaling receptor stops, prevents, or reduces the frequency, rate or extent of signal transduction. Receptor internalization can attenuate or reduce the strength of signaling by reducing the concentration of cell surface receptors available to ligands.


calcium ion import into vacuole

description: The directed movement of calcium cations into the vacuole across the vacuolar membrane.


name: copper ion transport across blood-brain barrier

description: The directed movement of copper (Cu) ions passing through the blood-brain barrier.


raffinose transport

description: The directed movement of raffinose into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Raffinose occurs in plants almost as commonly as sucrose and is present in cereal grains, cotton seeds, and many legumes. It is synthesized from sucrose by transfer of a galactopyranoside from myo-inositol.


synaptic vesicle endosomal processing

description: The process in which synaptic vesicles fuse to the presynaptic endosome followed by sorting of synaptic vesicle components and budding of new synaptic vesicles.


name: cytoplasm to vacuole targeting by the Cvt pathway

description: A cytoplasm to vacuole targeting pathway that uses machinery common with autophagy. The Cvt vesicle is formed when the receptor protein, Atg19, binds to the complexes of the target protein (aminopeptidase or alpha-mannosidase homododecamers), forming the Cvt complex. Atg11 binds to Atg9 and transports the Cvt complex to the pre-autophagosome (PAS). The phagophore membrane expands around the Cvt complex (excluding bulk cytoplasm) forming the Cvt vesicle. This pathway is mostly observed in yeast.


FAD transport

description: The directed movement of flavin-adenine dinucleotide (FAD) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. FAD forms the coenzyme of the prosthetic group of various flavoprotein oxidoreductase enzymes, in which it functions as an electron acceptor by being reversibly converted to its reduced form.


sulfur compound transport

description: The directed movement of compounds that contain sulfur, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.


abscisic acid transport

description: The directed movement of abscisic acid into, out of, within or between cells by means of some external agent such as a transporter or pore.


name: dynein-driven meiotic oscillatory nuclear movement

description: Oscillatory movement of the nucleus involved in meiosis I. This oscillatory movement is led by an astral microtubule array emanating from the spindle pole body, and driven by the microtubule motor cytoplasmic dynein.


malate import across plasma membrane

description: The directed movement of malate from outside of a cell, across the plasma membrane and into the cytosol.


name: release of sequestered calcium ion into presynaptic cytosol

description: The process in which calcium ions sequestered in the endoplasmic reticulum, Golgi apparatus or mitochondria are released into the presynaptic cytosol.


chromate transport

description: The directed movement of chromate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.


name: 3-hydroxyphenylpropionic acid transmembrane transport

description: The directed movement of 3-hydroxyphenylpropionic acid across a lipid bilayer, from one side of a membrane to the other.


name: L-arginine transmembrane transport from lysosomal lumen to cytosol

description: The directed movement of L-arginine across a membrane from lysosomal lumen to cytosol.


phytochelatin import into vacuole

description: The directed movement of phytochelatins into the vacuole. Phytochelatins are a group of peptides that bind metals (Cd, Zn, Cu, Pb, Hg) in thiolate coordination complexes.


name: caveolin-mediated endocytosis of virus by host cell

description: Any caveolin-mediated endocytosis that is involved in the uptake of a virus into a host cell. Begins when material is taken up into plasma membrane caveolae - specialized lipid rafts that form 50-70 nm flask-shaped invaginations of the plasma membrane - which then pinch off to form endocytic caveolar carriers containing the virus.


name: fructose export from vacuole to cytoplasm

description: The directed movement of fructose from vacuole to cytoplasm.


xanthine transport

description: The directed movement of xanthine into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Xanthine (2,6-dihydroxypurine) is a purine formed in the metabolic breakdown of guanine, but is not present in nucleic acids.


name: L-lysine transmembrane export from vacuole

description: The directed movement of L-lysine out of the vacuole, across the vacuolar membrane.


cysteine export across plasma membrane

description: The directed movement of cysteine from inside of a cell, across the plasma membrane and into the extracellular region.


ferric-enterobactin import into cell

description: A process in which ferric-enterobactin, the iron-bound form of the siderophore enterobactin, is transported into the cell by specific cell surface receptors.


N-acetylgalactosamine transport

description: The directed movement of N-acetylgalactosamine into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. N-acetylgalactosamine, 2-acetamido-2-deoxygalactopyranose, is the n-acetyl derivative of galactosamine.


D-methionine transmembrane transport

description: The process in which D-methionine is transported across a lipid bilayer, from one side of a membrane to the other.


name: positive regulation of toll-like receptor 9 signaling pathway by B cell receptor internalization

description: The movement of a B cell receptor (BCR) from the plasma membrane to the inside of the cell, which results in positive regulation of toll-like receptor 9 (TLR9) signaling. For example, internalized BCR signals to recruit TLR9 from multiple small endosomes to large autophagosome-like compartments to enhance TLR9 signaling.


nuclear axial expansion

description: The stepwise asymmetric spreading out of nuclei internally along the anterior-posterior axis of the developing insect embryo during mitotic cycles 4 to 6. This movement leads to the distribution of nuclei in a hollow ellipsoid underlying the cortex.


isopropylmalate transport

description: The directed movement of isopropylmalate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.


chlorate transport

description: The directed movement of chlorate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.


intermembrane sterol transfer

description: The transport of sterols between membranes in which a sterol molecule is transported through an aqueous phase from the outer leaflet of a donor membrane to the outer leaflet of an acceptor membrane. This process does not require metabolic energy and can be either spontaneous or mediated by lipid transfer proteins (LTPs).


intracellular nucleoside transport

description: The directed movement of a nucleoside, a nucleobase linked to either beta-D-ribofuranose (ribonucleoside) or 2-deoxy-beta-D-ribofuranose, (a deoxyribonucleotide), within a cell.


maltopentaose transport

description: The directed movement of a maltopentaoseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.


polyubiquitinated protein transport

description: The directed movement of polyubiquitinated proteins in a cell, including the movement of proteins between specific compartments or structures within a cell.


export from the mitochondrion

description: The directed movement of substances from the mitochondrion to the cytosol.


5-formyltetrahydrofolate transport

description: The directed movement of 5-formyltetrahydrofolate, the formylated derivative of tetrahydrofolate, into, out of, within, or between cells, by means of some agent such as a transporter or pore.


thromboxane transport

description: The directed movement of thromboxanes into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. A thromboxane is any of a class of oxygenated oxane derivatives, originally derived from prostaglandin precursors in platelets, that stimulate aggregation of platelets and constriction of blood vessels.


cyanate transport

description: The directed movement of cyanate, NCO-, the anion of cyanic acid, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.


DNA transport

description: The directed movement of RNA, deoxyribonucleic acid, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.


hexose phosphate transport

description: The directed movement of hexose phosphate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.


estrogen secretion

description: The regulated release of estrogen into the circulatory system. Estrogen is a steroid hormone that stimulates or controls the development and maintenance of female sex characteristics in mammals.


name: GDP-fucose import into endoplasmic reticulum lumen

description: The directed movement of GDP-fucose into the endoplasmic reticulum lumen. GDP-fucose is a substance composed of fucose in glycosidic linkage with guanosine diphosphate.


L-glutamate import into mitochondrion

description: The process in which L-glutamate is transported from the cytosol into the mitochondrial matrix.


amylase secretion

description: The controlled release of amylase from a cell.


antifungal peptide secretion

description: The regulated release of an antifungal peptide from a cell or a tissue.


description: The process in which 2-keto-3-deoxygluconate is transported across a lipid bilayer, from one side of a membrane to the other.


plasma membrane pyruvate transport

description: The directed movement of pyruvate, 2-oxopropanoate, across a plasma membrane.


name: phosphoenolpyruvate transmembrane import into Golgi lumen

description: The directed movement of phosphoenolpyruvate into the Golgi lumen across the Golgi membrane.


name: glutathione import across plasma membrane

description: The directed movement of glutathione from outside of a cell, across the plasma membrane and into the cytosol.


molybdate ion export from vacuole

description: The directed movement of molybdate ions out of the vacuole.


name: transmembrane L-cystine transport from lysosomal lumen to cytosol

description: The directed movement of L-cystine from the lysosomal lumen across the lysosomal membrane and into the cytosol.


clathrin-coated vesicle cargo loading

description: Formation of a macromolecular complex between the cytoplasmic coat proteins on clathrin-coated vesicles and proteins and/or lipoproteins that are going to be transported by a vesicle.


name: iron ion import across cell outer membrane

description: The directed movement of iron ions from outside of a cell, across the cell outer membrane and into the periplasmic space.


hexuronate transmembrane transport

description: The process in which hexuronate is transported across a lipid bilayer, from one side of a membrane to the other. A hexuronate is any monocarboxylic acid derived from a hexose by oxidation of C-6.


migracytosis

description: A cell migration-dependent mechanism for releasing cellular contents.


protein transport by the Sec complex

description: The process in which unfolded proteins are transported across the cytoplasmic membrane in Gram-positive and Gram-negative bacteria by the Sec complex, in a process involving proteolytic cleavage of an N-terminal signal peptide.


sulfate import across plasma membrane

description: The directed movement of sulfate from outside of a cell, across the plasma membrane and into the cytosol.


name: transmembrane phosphate ion transport from cytosol to vacuole

description: The directed movement of phosphate ions from the cytosol across the vacuolar membrane and into the vacuolar lumen.


name: histamine secretion involved in inflammatory response

description: The regulated release of histamine by a cell as part of an inflammatory response.


glycolate transmembrane transport

description: The process in which glycolate is transported across a membrane. Glycolate is the anion of hydroxyethanoic acid (glycolic acid).


sterol import

description: The directed movement of a sterol into a cell or organelle. Sterols are steroids with one or more hydroxyl groups and a hydrocarbon side-chain in the molecule.


description: The regulated release of catecholamine by a cell in which the catecholamine acts as a neurotransmitter.


name: oligopeptide import across plasma membrane

description: The directed movement of an oligopeptide from outside of a cell, across the plasma membrane and into the cytosol.


tyramine secretion, neurotransmission

description: The regulated release of a tyramine by a cell in which the tyramine acts as a neurotransmitter.


estradiol secretion

description: The regulated release of estradiol into the circulatory system.


endosome to pigment granule transport

description: The directed movement of substances from endosomes to pigment granules.


bacteriocin transport

description: The directed movement of a bacteriocin into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Bacteriocins are a group of antibiotics produced by bacteria and are encoded by a group of naturally occurring plasmids, e.g. Col E1. Bacteriocins are toxic to bacteria closely related to the bacteriocin producing strain.


urea import across plasma membrane

description: The directed movement of urea from outside of a cell, across the plasma membrane and into the cytosol.


allantoin transport

description: The directed movement of allantoin, (2,5-dioxo-4-imidazolidinyl)urea, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.


aldonate transmembrane transport

description: The process in which aldonate is transported across a lipid bilayer, from one side of a membrane to the other.


apolipoprotein E recycling

description: The process in which chylomicron remnant-associated apolipoprotein E is internalized by endocytosis, localized to recycling endosomes and then secreted in association with a high-density lipoprotein particle.


corticosteroid hormone secretion

description: The regulated release of any corticosteroid hormone into the circulatory system.


name: vacuolar amino acid transmembrane transport

description: The process in which an amino acid is transported from one side of the vacuolar membrane to the other.


axonal dopamine secretion

description: The regulated release of dopamine from an axon.


name: L-arginine transmembrane export from vacuole

description: The directed movement of L-arginine out of the vacuole, across the vacuolar membrane.


substance P secretion

description: The regulated release of substance P, a peptide hormone that is involved in neurotransmission, inflammation, and antimicrobial activity.


name: primary amine secretion, neurotransmission

description: The regulated release of a primary amine by a cell, in which the primary amine acts as a neurotransmitter.


dense core granule transport

description: The directed movement a dense core granule within a cell.


pancreatic trypsinogen secretion

description: The regulated release of trypsinogen from the cells of the exocrine pancreas.


dopamine secretion, neurotransmission

description: The regulated release of dopamine by a cell in which the dopamine acts as a neurotransmitter.


hexuronide transmembrane transport

description: The directed movement of hexuronide across a membrane. Hexuronides are any compound formed by combination of glycosidic linkage of a hydroxy compound (e.g. an alcohol or a saccharide) with the anomeric carbon atom of a hexuronate.


arabinan transmembrane transport

description: The process in which arabinan is transported across a lipid bilayer, from one side of a membrane to the other.


antimonite transmembrane transport

description: The directed movement of antimonite into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.


description: The directed, sodium-independent, movement of leukotrienes into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Leukotrienes are linear C20 endogenous metabolites of arachidonic acid (icosa-5,8,11,14-tetraenoic acid) containing a terminal carboxy function and four or more double bonds (three or more of which are conjugated) as well as other functional groups.


primary amine secretion

description: The regulated release of a primary amine by a cell.


group A colicin transport

description: The directed movement of group A colicins (colicins E1, E2, E3, A, K, and N) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.


carbohydrate export

description: The directed movement of carbohydrates out of a cell or organelle.


3-hydroxyphenyl propanoate transport

description: The directed movement of 3-hydroxyphenyl propanoate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.


pyridoxal transport

description: The directed movement of pyridoxal into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Pyridoxal, 3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinecarboxaldehyde, is one of the vitamin B6 compounds. Pyridoxal, pyridoxamine and pyridoxine are collectively known as vitamin B6, and are efficiently converted to the biologically active form of vitamin B6, pyridoxal phosphate.


octopamine secretion, neurotransmission

description: The controlled release of octopamine by a cell, in which the octopamine acts as a neurotransmitter.


name: mitochondrial sulfate transmembrane transport

description: The process in which sulfate is transported across a mitochondrial membrane, into or out of the mitochondrion.


magnesium ion export from mitochondrion

description: The directed movement of magnesium ions out of mitochondrial matrix into the cytosol by means of some agent such as a transporter or pore.


embryo sac nuclear migration

description: The directed movement of an embryo sac nucleus to the pole or center of the cell.


trisaccharide transport

description: The directed movement of a trisaccharideacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.


maltose import across plasma membrane

description: The directed movement of maltose from outside of a cell, across the plasma membrane and into the cytosol.


protein transport by the Tat complex

description: The process in which folded proteins are transported across cytoplasmic membranes of bacteria and membranes of organelles derived from bacteria (chloroplasts and mitochondria) by the TAT complex.


nucleic acid transport

description: The directed movement of nucleic acids, single or double-stranded polynucleotides involved in the storage, transmission and transfer of genetic information, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.


cutin transport

description: The directed movement of cutin into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Cutin, which consists of C16-18 fatty acids, is the major component of the cuticle that covers the plant surface.


name: ferric triacetylfusarinine C import into cell

description: The directed movement of ferric triacetylfusarinine C into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.


D-allose transmembrane transport

description: The process in which D-allose is transported across a lipid bilayer, from one side of a membrane to the other. Allose is an aldohexose similar to glucose, differing only in the configuration of the hydroxyl group of C-3.


polyamine transport

description: The directed movement of polyamines, organic compounds containing two or more amino groups, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.


sulfur amino acid transport

description: The directed movement of amino acids containing sulfur (cystine, methionine and their derivatives) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.


name: glutamate transmembrane import into vacuole

description: The directed movement of glutamate into the vacuole across the vacuolar membrane.


catecholamine transport

description: The directed movement of catecholamines, a group of physiologically important biogenic amines that possess a catechol (3,4-dihydroxyphenyl) nucleus and are derivatives of 3,4-dihydroxyphenylethylamine.


steroid hormone secretion

description: The regulated release of any steroid that acts as a hormone into the circulatory system.


name: protein transport across the cell outer membrane

description: The directed movement of proteins across the cell outer membrane.


serotonin secretion, neurotransmission

description: The regulated release of serotonin by a cell, in which released serotonin acts as a neurotransmitter.


description: The directed, sodium-independent, movement of prostaglandins into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.


synaptic vesicle recycling via endosome

description: Synaptic vesicle recycling where vesicles endocytosed via clathrin-coated pits re-acidify and refill with neurotransmitters after passing through an endosomal intermediate.


maltotriulose transport

description: The directed movement of a maltotriuloseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.


galactitol transmembrane transport

description: The directed movement of galactitol across a membrane. Galactitol is the hexitol derived by the reduction of the aldehyde group of either D- or L-galactose.


maltotriose transport

description: The directed movement of a maltotrioseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.


name: UDP-beta-L-arabinofuranose import into Golgi lumen

description: The directed movement of UDP-beta-L-arabinofuranose from the cytosol to the Golgi apparatus of a cell.


signal release from synapse

description: Any signal release from a synapse.


tricarboxylic acid transport

description: The directed movement of tricarboxylic acids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.


fluoride export across plasma membrane

description: The directed movement of fluoride ions from inside of a cell, across the plasma membrane and into the extracellular region.


name: L-lysine import into vacuole involved in cellular response to nitrogen starvation

description: A L-lysine import into the vacuole that is involved in cellular response to nitrogen starvation.


basipetal auxin transport

description: The unidirectional movement of auxin from the apex to base of an organ, including the shoot, leaf, primary root, or lateral root.


orexin secretion

description: The controlled release of orexin from a cell or a tissue.


prostaglandin receptor internalization

description: The process that results in the uptake of a prostaglandin receptor into an endocytic vesicle.


uracil import across plasma membrane

description: The directed movement of uracil from outside of a cell, across the plasma membrane and into the cytosol.


name: peptide pheromone export by transmembrane transport

description: The directed movement of a peptide pheromone across a membrane and out of a cell.


name: mating pheromone secretion involved in regulation of conjugation with cellular fusion

description: The regulated release of a mating pheromone, a peptide hormone that induces a behavioral or physiological response(s) from a responding organism or cell, that regulates the union or introduction of genetic information from compatible mating types that results in a genetically different individual. Conjugation requires direct cellular contact between the organisms.


catecholamine uptake

description: The directed movement of catecholamine into a cell.


import into the mitochondrion

description: The directed movement of substances from the cytosol into the mitochondrion.


testosterone secretion

description: The regulated release of testosterone into the circulatory system. Testosterone is an androgen having 17beta-hydroxy and 3-oxo groups, together with unsaturation at C-4-C-5.


dentin extracellular matrix secretion

description: The regulated release by odontoblasts of the extracellular matrix constituents, including collagen, that form the basis of dentin.


pyridoxal phosphate transport

description: The directed movement of pyridoxal phosphate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore; pyridoxal phosphate is pyridoxal phosphorylated at the hydroxymethyl group of C-5, and is the active form of vitamin B6.


peptide pheromone export

description: The directed movement of a peptide pheromone out of a cell by a secretion or export pathway used solely for the export of peptide pheromones.


one-carbon compound transport

description: The directed movement of one-carbon compounds into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.


arbutin transport

description: The directed movement of arbutin, a glycoside found in the bearberry and related plants which has been used to treat urinary-tract diseases, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.


peptide pheromone secretion

description: The regulated release of a peptide pheromone from a cell.


laminaritriose transport

description: The directed movement of a laminaritrioseacetate into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.


name: carbohydrate import across plasma membrane

description: The directed movement of a carbohydrate from outside of a cell, across the plasma membrane and into the cytosol.


name: cargo loading involved in clathrin-dependent endocytosis

description: Formation of a macromolecular complex during clathrin-dependent endocytosis that connects the assembling clathrin coat to the proteins and/or lipoproteins to be transported in an endocytic vesicle. This complex includes a receptor and an adaptor protein that links the receptor to the clathrin coat.


name: secretion by the type IV secretion system

description: The controlled release of proteins or DNA by a cell, via the type IV secretion system.


name: histamine-induced gastric acid secretion

description: The regulated release of gastric acid induced by the interaction of histamine with H2 type receptor receptors with subsequent activation of adenylate cyclase and elevation of intracellular cyclic AMP.


pyridoxal import across plasma membrane

description: The directed movement of pyridoxal from outside of a cell, across the plasma membrane and into the cytosol.


cellular response to micafungin

description: Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a micafungin stimulus.


response to micafungin

description: Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a micafungin stimulus.


name: collagen alpha-1(II) chain cysteinylated 1 (human)

description: A collagen alpha-1(II) chain (human) that has been cysteinylated on the residue at the position equivalent to Cys-1393 of the amino acid sequence represented by UniProtKB:P02458-2. Example: UniProtKB:P02458-2, Cys-1393, MOD:00765.


lysophosphatidic acid receptor 1

A lysophospholipid (LPA) receptor that is a translation product of the human LPAR1 gene or a 1:1 ortholog thereof. It is expressed in many adult organs, including brain, heart, colon, small intestine, placenta, prostate, ovary, pancreas, testis, spleen, skeletal muscle, and kidney. There is little or no expression in liver, lung, thymus, or peripheral blood leukocytes.


name: lysophosphatidic acid receptor 1 isoform 1 (human)

description: A lysophosphatidic acid receptor 1 isoform 1 that is encoded in the genome of human.


name: lysophosphatidic acid receptor 1 isoform h2 (human)

description: A lysophosphatidic acid receptor 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q92633-2.


name: negative regulation of protein O-linked glycosylation

description: Any process that stops, prevents or reduces the frequency, rate or extent of protein O-linked glycosylation.


apical dendrite development

description: The process whose specific outcome is the progression of an apical dendrite over time, from its formation to the mature structure.


name: cation-independent mannose-6-phosphate receptor deaminated 4 (human)

description: A cation-independent mannose-6-phosphate receptor (human) that has been deaminated on the residue at the position equivalent to Gln-777 of the amino acid sequence represented by UniProtKB:P11717. UniProtKB:P11717, Gln-777, MOD:00685.


name: positive regulation of optical nerve axon regeneration

description: Any process that activates or increases the frequency, rate or extent of optical nerve axon regeneration.


name: negative regulation of sprouting of injured axon

description: Any process that stops, prevents, or reduces the frequency, rate or extent of sprouting of an injured axon.


name: negative regulation of collateral sprouting of injured axon

description: Any process that stops, prevents, or reduces the frequency, rate or extent of collateral sprouting of an injured axon.


name: positive regulation of formation of growth cone in injured axon

description: Any process that activates or increases the frequency, rate or extent of formation of growth cone in injured axon.


name: positive regulation of collateral sprouting of intact axon in response to injury

description: Any process that activates, maintains or increases the rate of collateral sprouting of an intact axon as a result of injury to an axon.


name: negative regulation of formation of growth cone in injured axon

description: Any process that stops, prevents or reduces the frequency, rate or extent of formation of growth cone in injured axon.


name: positive regulation of neuron projection regeneration

description: Any process that activates or increases the frequency, rate or extent of neuron projection regeneration, the regrowth of neuronal processes such as axons or dendrites following their loss or damage.


name: regulation of optical nerve axon regeneration

description: Any process that modulates the frequency, rate or extent of optical nerve axon regeneration.


name: positive regulation of axon extension involved in regeneration

description: Any process that activates, maintains or increases the rate of axon extension involved in regeneration.


name: positive regulation of collateral sprouting of injured axon

description: Any process that activates, maintains or increases the rate of collateral sprouting of an injured axon.


name: regulation of collateral sprouting of intact axon in response to injury

description: Any process that modulates the frequency, rate or extent of collateral sprouting of an intact axon as a result of injury to an axon.


name: PALM2-AKAP2 fusion protein cysteinylated 1 (human)

description: A PALM2-AKAP2 fusion protein (human) that has been cysteinylated on the residue at the position equivalent to Cys-436 of the amino acid sequence represented by UniProtKB:Q9Y2D5-4. Example: UniProtKB:Q9Y2D5-4, Cys-436, MOD:00765.


name: nuclear pore complex protein Nup107 deaminated 1 (human)

description: A nuclear pore complex protein Nup107 (human) that has been deaminated on the residue at the position equivalent to Gln-870 of the amino acid sequence represented by UniProtKB:P57740-1. Example: UniProtKB:P57740-1, Gln-870, MOD:00685.


name: NADH dehydrogenase [ubiquinone] 1 subunit C2 methylated 1 (human)

description: An NADH dehydrogenase [ubiquinone] 1 subunit C2 (human) that has been methylated on the residue at the position equivalent to Phe-115 of the amino acid sequence represented by UniProtKB:O95298-1. Example: UniProtKB:O95298-1, Phe-115, MOD:00717.


name: NADH dehydrogenase [ubiquinone] 1 subunit C2

description: A protein that is a translation product of the human NDUFC2 gene or a 1:1 ortholog thereof.


name: NADH dehydrogenase [ubiquinone] 1 subunit C2 isoform 3 (human)

description: An NADH dehydrogenase [ubiquinone] 1 subunit C2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O95298-1.


name: NADH dehydrogenase [ubiquinone] 1 subunit C2 isoform 5 (human)

description: An NADH dehydrogenase [ubiquinone] 1 subunit C2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O95298-3.


name: NADH dehydrogenase [ubiquinone] 1 subunit C2 isoform 4 (human)

description: An NADH dehydrogenase [ubiquinone] 1 subunit C2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O95298-2.


name: regulation of isotype switching to IgD isotypes

description: Any process that modulates the frequency, rate or extent of isotype switching to IgD isotypes.


name: negative regulation of isotype switching to IgG isotypes

description: Any process that stops, prevents, or reduces the frequency, rate or extent of isotype switching to IgG isotypes.


name: positive regulation of isotype switching to IgD isotypes

description: Any process that activates or increases the frequency, rate or extent of isotype switching to IgD isotypes.


name: regulation of immunoglobulin production in mucosal tissue

description: Any process that modulates the frequency, rate or extent of immunoglobulin production in mucosal tissue.


name: regulation of isotype switching to IgA isotypes

description: Any process that modulates the frequency, rate or extent of isotype switching to IgA isotypes.


name: negative regulation of isotype switching to IgD isotypes

description: Any process that stops, prevents, or reduces the frequency, rate or extent of isotype switching to IgD isotypes.


name: regulation of isotype switching to IgE isotypes

description: Any process that modulates the frequency, rate or extent of isotype switching to IgE isotypes.


name: negative regulation of isotype switching to IgA isotypes

description: Any process that stops, prevents, or reduces the frequency, rate or extent of isotype switching to IgA isotypes.


name: regulation of interleukin-4-dependent isotype switching to IgE isotypes

description: Any process that modulates the frequency, rate or extent of interleukin-4-dependent isotype switching to IgE isotypes.


name: DNA-directed RNA polymerase II subunit RPB7 cysteinylated 2 (human)

description: A DNA-directed RNA polymerase II subunit RPB7 (human) that has been cysteinylated on the residue at the position equivalent to Cys-106 of the amino acid sequence represented by UniProtKB:P62487. UniProtKB:P62487, Cys-106, MOD:00765.


name: homeobox and leucine zipper protein Homez

description: A protein that is a translation product of the human HOMEZ gene or a 1:1 ortholog thereof.


name: homeobox and leucine zipper protein Homez isoform h1 (human)

description: A homeobox and leucine zipper protein Homez (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8IX15-1.


name: homeobox and leucine zipper protein Homez isoform h2 (human)

description: A homeobox and leucine zipper protein Homez (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8IX15-3.


name: negative regulation of translational fidelity

description: Any process that decreases the ability of the translational apparatus to interpret the genetic code.


DnaJ homolog subfamily C member 15

A protein that is a translation product of the human DNAJC15 gene or a 1:1 ortholog thereof.


name: G protein-coupled receptor kinase 6 isoform GRK6A (human)

description: A G protein-coupled receptor kinase 6 isoform 1 that is encoded in the genome of human.


name: histone H3.2, initiator methionine removed acetylated and phosphorylated 3 (human)

description: A histone H3.2 (human) that has had the initiator methionine removed and that has been acetylated on the residues at the positions equivalent to Lys-15 and Lys-19 and phosphorylated on the residue at the position equivalent to Ser-11 of the amino acid sequence represented by UniProtKB:Q71DI3. UniProtKB:Q71DI3, 2-136, Ser-11, MOD:00046|Lys-15/Lys-19, MOD:00064.


name: post-embryonic plant organ morphogenesis

description: Morphogenesis, during the post-embryonic phase, of a plant tissue or tissues that work together to perform a specific function or functions. Morphogenesis pertains to process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.


post-embryonic plant morphogenesis

description: The process, occurring after plant embryonic development, by which anatomical structures are generated and organized.


carpel structural organization

description: The process that contributes to the act of creating the structural organization of the carpel. This process pertains to the physical shaping of a rudimentary structure.


stamen structural organization

description: The process that contributes to the act of creating the structural organization of the stamen. This process pertains to the physical shaping of a rudimentary structure.


plant ovule morphogenesis

description: The process in which the anatomical structures of the ovule are generated and organized. The ovule is the structure in seed plants enclosing the female gametophyte, and is composed of the nucellus, one or two integuments, and the funiculus; it develops into the seed.


stamen morphogenesis

description: The process in which the anatomical structures of the stamen are generated and organized.


anther morphogenesis

description: The process in which the anatomical structures of the anther are generated and organized.


post-embryonic root morphogenesis

description: The process in which the anatomical structures of the post-embryonic root are generated and organized. The post-embryonic root is the root formed after the embryonic phase has been completed.


petal morphogenesis

description: The process in which the anatomical structures of the petal are generated and organized.


lateral root morphogenesis

description: The process in which the anatomical structures of a lateral root are generated and organized. A lateral root is one formed from pericycle cells located on the xylem radius of the root, as opposed to the initiation of the main root from the embryo proper.


floral whorl morphogenesis

description: The process in which the anatomical structures of the floral whorl are generated and organized.


sepal morphogenesis

description: The process in which the anatomical structures of the sepal are generated and organized.


floral organ morphogenesis

description: The process in which the anatomical structures of the floral organ are generated and organized.


sepal structural organization

description: The process that contributes to the act of creating the structural organization of the sepal. This process pertains to the physical shaping of a rudimentary structure.


carpel morphogenesis

description: The process in which the anatomical structures of the carpel are generated and organized.


flower morphogenesis

description: The process in which the anatomical structures of the flower are generated and organized.


description: The process in which the anatomical structures of determinate inflorescences are generated and organized. A determinate inflorescence is one that can produce an undefined number of floral meristems.


guard cell morphogenesis

description: Generation and organization of the polarized cell that is capable of turgor driven movement.


petal structural organization

description: The process that contributes to the act of creating the structural organization of the petal. This process pertains to the physical shaping of a rudimentary structure.


fruit morphogenesis

description: The process in which the anatomical structures of a fruit are generated and organized. A fruit is a reproductive body of a seed plant.


determinate inflorescence morphogenesis

description: The process in which the anatomical structures of determinate inflorescences are generated and organized. A determinate inflorescence is one that can only produce a predetermined number of floral meristems.


stomatal complex morphogenesis

description: The process in which the anatomical structures of the stomatal complex are generated and organized. The stomatal complex is the stomatal guard cells and their associated epidermal cells.


seed morphogenesis

description: The process in which the anatomical structures of the seed are generated and organized.


inflorescence morphogenesis

description: The process in which the anatomical structures of inflorescences are generated and organized. An inflorescence is the part of a seed plant body that is usually above ground and that can bear flowers.


floral organ structural organization

description: The process that contributes to the act of creating the structural organization of floral organs. This process pertains to the physical shaping of a rudimentary structure.


anther wall tapetum morphogenesis

description: The process in which the anatomical structures of the anther wall tapetum are generated and organized. The anther wall tapetum is a layer of cells that provides a source of nutrition for the pollen grains as they mature.


cotyledon morphogenesis

description: The process in which the anatomical structures of the cotyledon are generated and organized. The cotyledon is the modified leaf (seed leaf), found as part of the embryo in plant seeds. It is involved in either storage or absorption of food reserves. Dicotyledonous seeds contain two cotyledons, while monocotyledonous seeds contain only one. The cotyledons may appear above ground and show photosynthetic activity in the seedling.


name: tumor protein p53-inducible protein 11 isoform 1 (human)

description: A tumor protein p53-inducible protein 11 isoform 1 that is encoded in the genome of human.


ventral aorta development

description: The progression of the ventral aorta over time, from its initial formation to the mature structure. The ventral aorta is a blood vessel in a single-pass circulatory system that carries de-oxygenated blood from the heart to the gills. In a single-pass circulatory system blood passes once through the heart to supply the body once.


name: mesonephric glomerulus vasculature development

description: The biological process whose specific outcome is the progression of a mesonephric glomerulus vasculature from an initial condition to its mature state. This process begins with the formation of the mesonephric glomerulus vasculature and ends with the mature structure. The mesonephric glomerulus vasculature is composed of the tubule structures that carry blood or lymph in the mesonephric glomerulus.


name: ATP-binding cassette sub-family B member 10, mitochondrial methylated 1 (human)

description: An ATP-binding cassette sub-family B member 10, mitochondrial (human) that has been methylated on the residue at the position equivalent to Cys-100 of the amino acid sequence represented by UniProtKB:Q9NRK6. UniProtKB:Q9NRK6, Cys-100, MOD:00660.


name: pleckstrin homology domain-containing family B member 1 isoform 1 (human)

description: A pleckstrin homology domain-containing family B member 1 isoform 1 that is encoded in the genome of human.


name: serotransferrin N-glycosylated 35 (human)

description: A serotransferrin (human) that has been N-glycosylated at the residue equivalent to Asn-630 of the amino acid sequence represented by UniProtKB:P02787-1, in which the glycan structure is represented by GlyTouCan:G36191CD. Example: UniProtKB:P02787-1, Asn-630, MOD:00160~GNO:G36191CD.


name: aryl hydrocarbon receptor deaminated 1 (human)

description: An aryl hydrocarbon receptor (human) that has been deaminated on the residue at the position equivalent to Asn-105 of the amino acid sequence represented by UniProtKB:P35869. UniProtKB:P35869, Asn-105, MOD:00684.


immunoglobulin heavy constant gamma 1

A protein that is a translation product of the human IGHG1 gene or a 1:1 ortholog thereof.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 32 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G60923RB. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G60923RB.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 40 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G72791KH. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G72791KH.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 30 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G59626AS. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G59626AS.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 47 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G85582CB. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G85582CB.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 51 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G90734RJ. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G90734RJ.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 5 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G08293MJ. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G08293MJ.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 21 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G44953PJ. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G44953PJ.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 52 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G95865ZB. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G95865ZB.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 33 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G61855PQ. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G61855PQ.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 25 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G52162PS. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G52162PS.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 17 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G35029YA. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G35029YA.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 34 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G65184UU. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G65184UU.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 14 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G25987BV. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G25987BV.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 10 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G12580WI. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G12580WI.


name: immunoglobulin heavy constant gamma 1 deaminated 2 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been deaminated on the residue at the position equivalent to Asn-86 of the amino acid sequence represented by UniProtKB:P01857-2. Example: UniProtKB:P01857-2, Asn-86, MOD:00684.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 18 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan structure is represented by GlyTouCan:G36191CD. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G36191CD.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 7 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G10339FR. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G10339FR.


name: immunoglobulin heavy constant gamma 1 deaminated 7 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been deaminated on the residue at the position equivalent to Gln-245 of the amino acid sequence represented by UniProtKB:P01857-2. Example: UniProtKB:P01857-2, Gln-245, MOD:00685.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 6 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G09197ZW. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G09197ZW.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 8 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G10486CT. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G10486CT.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 16 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan structure is represented by GlyTouCan:G30159WR. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G30159WR.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 44 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G83555HU. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G83555HU.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 35 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G72790NZ. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G72790NZ.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 13 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan structure is represented by GlyTouCan:G25520XG. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G25520XG.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 23 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G49955PK. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G49955PK.


name: immunoglobulin heavy constant gamma 1 deaminated 1 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been deaminated on the residue at the position equivalent to Gln-79 of the amino acid sequence represented by UniProtKB:P01857-2. Example: UniProtKB:P01857-2, Gln-79, MOD:00685.


name: immunoglobulin heavy constant gamma 1 deaminated 3 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been deaminated on the residue at the position equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2. Example: UniProtKB:P01857-2, Asn-180, MOD:00684.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 50 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G88725PI. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G88725PI.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 36 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G67324HN. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G67324HN.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 37 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G68318VE. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G68318VE.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 3 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G02886BB. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G02886BB.


name: immunoglobulin heavy constant gamma 1 deaminated 5 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been deaminated on the residue at the position equivalent to Asn-84 of the amino acid sequence represented by UniProtKB:P01857-2. Example: UniProtKB:P01857-2, Asn-84, MOD:00684.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 48 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G85740DB. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G85740DB.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 9 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan structure is represented by GlyTouCan:G11254FL. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G11254FL.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 31 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G59937CP. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G59937CP.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 20 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G40834TG. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G40834TG.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 11 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan structure is represented by GlyTouCan:G22674CI. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G22674CI.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 22 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G45504EY. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G45504EY.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 28 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G57317CE. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G57317CE.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 46 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G83646BJ. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G83646BJ.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 24 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G50073PQ. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G50073PQ.


name: immunoglobulin heavy constant gamma 1 deaminated 9 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been deaminated on the residue at the position equivalent to Asn-267 of the amino acid sequence represented by UniProtKB:P01857-2. Example: UniProtKB:P01857-2, Asn-267, MOD:00684.


name: immunoglobulin heavy constant gamma 1 deaminated 6 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been deaminated on the residue at the position equivalent to Gln-269 of the amino acid sequence represented by UniProtKB:P01857-2. Example: UniProtKB:P01857-2, Gln-269, MOD:00685.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 43 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan structure is represented by GlyTouCan:G80858MF. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G80858MF.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 42 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G80475RE. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G80475RE.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 49 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G88374WZ. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G88374WZ.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 2 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G02815KT. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G02815KT.


name: immunoglobulin heavy constant gamma 1 isoform h2 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P01857-2.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 27 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G72787SB. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G72787SB.


name: immunoglobulin heavy constant gamma 1 deaminated 4 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been deaminated on the residue at the position equivalent to Asn-244 of the amino acid sequence represented by UniProtKB:P01857-2. Example: UniProtKB:P01857-2, Asn-244, MOD:00684.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 19 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan structure is represented by GlyTouCan:G39213VZ. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G39213VZ.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 15 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G28603RA. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G28603RA.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 4 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G57776ZU. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G57776ZU.


name: immunoglobulin heavy constant gamma 1 deaminated 8 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been deaminated on the residue at the position equivalent to Asn-272 of the amino acid sequence represented by UniProtKB:P01857-2. Example: UniProtKB:P01857-2, Asn-272, MOD:00684.


name: immunoglobulin heavy constant gamma 1 isoform h1 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P01857-1.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 1 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G00912UN.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 45 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G83633GK. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G83633GK.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 26 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G54600FO. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G54600FO.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 41 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan structure is represented by GlyTouCan:G78059CC. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G78059CC.


name: immunoglobulin heavy constant gamma 1 N-glycosylated 12 (human)

description: An immunoglobulin heavy constant gamma 1 (human) that has been N-glycosylated at the residue equivalent to Asn-180 of the amino acid sequence represented by UniProtKB:P01857-2, in which the glycan composition is represented by GlyTouCan:G25079LO. Example: UniProtKB:P01857-2, Asn-180, MOD:00160~GNO:G25079LO.


name: eIF-2-alpha kinase GCN2 isoform h1 (human)

description: An eIF-2-alpha kinase GCN2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9P2K8-1.


protein FAM171A2

A protein that is a translation product of the human FAM171A2 gene or a 1:1 ortholog thereof.


name: bifunctional phosphoribosylaminoimidazole carboxylase/phosphoribosylaminoimidazole succinocarboxamide synthetase isoform 1 (human)

description: A bifunctional phosphoribosylaminoimidazole carboxylase/phosphoribosylaminoimidazole succinocarboxamide synthetase isoform 1 that is encoded in the genome of human.


A cadherin that is a translation product of the human CDH15 gene or a 1:1 ortholog thereof.


name: serine/threonine-protein kinase Nek2 isoform h3 (human)

description: A serine/threonine-protein kinase Nek2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P51955-3.


nitrogenase activity

category: biolink:MolecularActivity biolink:Occurrent biolink:OntologyClass biolink:BiologicalProcessOrActivity biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing biolink:PhysicalEssenceOrOccurrent

description: Catalysis of the reaction: 8 reduced ferredoxin + 8 H+ + N2 + 16 ATP + 16 H2O = 8 oxidized ferredoxin + 2 NH3 + 16 ADP + 16 phosphate.


ethyl acetate metabolic process

description: The chemical reactions and pathways involving ethyl acetate.


ethyl acetate biosynthetic process

description: The chemical reactions and pathways resulting in the formation of ethyl acetate.


name: zinc finger protein 385A isoform h2 (human)

description: A zinc finger protein 385A (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96PM9-2.


name: transmembrane protein 126A acetylated 1 (human)

description: A transmembrane protein 126A that is N-terminal Met acetylated in human. Example: UniProtKB:Q9H061-1, Met-1, MOD:00058.


dickkopf-like protein 1

A protein that is a translation product of the human DKKL1 gene or a 1:1 ortholog thereof.


name: ubiquitin carboxyl-terminal hydrolase 43 isoform h1 (human)

description: A ubiquitin carboxyl-terminal hydrolase 43 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q70EL4-1.


name: olfactory receptor 6B3 deaminated 1 (human)

description: An olfactory receptor 6B3 (human) that has been deaminated on the residue at the position equivalent to Asn-42 of the amino acid sequence represented by UniProtKB:Q8NGW1. UniProtKB:Q8NGW1, Asn-42, MOD:00684.


name: vitamin K-dependent protein C N-glycosylated 25 (human)

description: A vitamin K-dependent protein C (human) that has been N-glycosylated at the residue equivalent to Asn-355 of the amino acid sequence represented by UniProtKB:P04070-1, in which the glycan structure is represented by GlyTouCan:G42440OJ. Example: UniProtKB:P04070-1, Asn-355, MOD:00160~GNO:G42440OJ.


name: huntingtin-interacting protein 1 deaminated 1 (human)

description: A huntingtin-interacting protein 1 (human) that has been deaminated on the residue at the position equivalent to Gln-200 of the amino acid sequence represented by UniProtKB:O00291-1. Example: UniProtKB:O00291-1, Gln-200, MOD:00685.


name: serine-rich and transmembrane domain-containing 2

description: A protein that is a translation product of the human SERTM2 gene or a 1:1 ortholog thereof.


rhotekin phosphorylated 1 (human)

A rhotekin (human) that has been phosphorylated on the residue at the position equivalent to Thr-465 of the amino acid sequence represented by UniProtKB:Q9BST9-1. Example: UniProtKB:Q9BST9-1, Thr-465, MOD:00047.


name: cell division cycle protein 27 homolog deaminated 1 (human)

description: A cell division cycle protein 27 homolog (human) that has been deaminated on the residue at the position equivalent to Gln-326 of the amino acid sequence represented by UniProtKB:P30260-1. Example: UniProtKB:P30260-1, Gln-326, MOD:00685.


name: terminal acetylenic compound catabolic process

description: The chemical reactions and pathways resulting in the breakdown of a terminal acetylenic compound, a compound which contains a terminal alkyne moiety in which a carbon of the carbon-carbon triple bond (aka C#C) moiety is attached to a hydrogen atom.


name: terminal acetylenic compound metabolic process

description: The chemical reactions and pathways involving a terminal acetylenic compound, involving a terminal acetylenic compound, a compound which contains a terminal alkyne moiety in which which a carbon of the carbon-carbon triple bond (aka C#C) moiety is attached to a hydrogen atom.


anaerobic acetylene catabolic process

description: The chemical reactions and pathways involving acetylene, a colorless, volatile, explosive gas, that occur in the absence of oxygen.


acetylene metabolic process

description: The chemical reactions and pathways involving acetylene, formula CH2CH2, the simplest of the alkynes.


name: terminal acetylenic compound biosynthetic process

description: The chemical reactions and pathways resulting in the formation of a terminal acetylenic compound, a compound which contains a terminal alkyne moiety in which a carbon of the carbon-carbon triple bond (aka C#C) moiety is attached to a hydrogen atom.


uromodulin N-glycosylated 389 (human)

A uromodulin (human) that has been N-glycosylated at the residue equivalent to Asn-80 of the amino acid sequence represented by UniProtKB:P07911-1, in which the glycan structure is represented by GlyTouCan:G33241WC. Example: UniProtKB:P07911-1, Asn-80, MOD:00160~GNO:G33241WC.


fungal-type cell wall biogenesis

description: A cellular process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of a fungal-type cell wall. The fungal-type cell wall contains beta-glucan and may contain chitin.


ascospore wall biogenesis

description: A cellular process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of an ascospore wall.


name: cellular tumor antigen p53 sequence variant K132* (human)

description: A cellular tumor antigen p53 (human) that has has been truncated after the position equivalent to Asn-131 of the amino acid sequence represented by UniProtKB:P04637-1. Example: UniProtKB:P04637-1, 1-131.


name: E3 ubiquitin-protein ligase DTX1 cysteinylated 1 (human)

description: An E3 ubiquitin-protein ligase DTX1 (human) that has been cysteinylated on the residue at the position equivalent to Cys-349 of the amino acid sequence represented by UniProtKB:Q86Y01. UniProtKB:Q86Y01, Cys-349, MOD:00765.


E3 ubiquitin-protein ligase DTX1

A protein that is a translation product of the human DTX1 gene or a 1:1 ortholog thereof.


protein-tRNA adaptor activity

description: The binding activity of a protein that brings together another protein and a tRNA, permitting those molecules to function in a coordinated way.


name: aggrecan core protein O-glycosylated 84 (human)

description: An aggrecan core protein (human) that has been O-glycosylated at the residue equivalent to Thr-2223 of the amino acid sequence represented by UniProtKB:P16112-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P16112-1, Thr-2223, MOD:00005~GNO:G53434XO.


name: alpha-fetoprotein N-glycosylated 13 (human)

description: An alpha-fetoprotein (human) that has been N-glycosylated at the residue equivalent to Asn-251 of the amino acid sequence represented by UniProtKB:P02771-1, in which the glycan structure is represented by GlyTouCan:G43694RQ. Example: UniProtKB:P02771-1, Asn-251, MOD:00160~GNO:G43694RQ.


name: E3 ubiquitin-protein ligase NEDD4-like isoform h2 (human)

description: An E3 ubiquitin-protein ligase NEDD4-like (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96PU5-2.


name: N-acetylmuramoyl-L-alanine amidase O-glycosylated 9 (human)

description: An N-acetylmuramoyl-L-alanine amidase (human) that has been O-glycosylated at the residue equivalent to Thr-182 of the amino acid sequence represented by UniProtKB:Q96PD5-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q96PD5-1, Thr-182, MOD:00005~GNO:G43417UB.


name: N-acetylmuramoyl-L-alanine amidase N-glycosylated 3 (human)

description: An N-acetylmuramoyl-L-alanine amidase (human) that has been N-glycosylated at the residue equivalent to Asn-485 of the amino acid sequence represented by UniProtKB:Q96PD5-1, in which the glycan structure is represented by GlyTouCan:G42358LZ. Example: UniProtKB:Q96PD5-1, Asn-485, MOD:00160~GNO:G42358LZ.


name: N-acetylmuramoyl-L-alanine amidase isoform h2 (human)

description: An N-acetylmuramoyl-L-alanine amidase (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96PD5-2.


name: N-acetylmuramoyl-L-alanine amidase O-glycosylated 3 (human)

description: An N-acetylmuramoyl-L-alanine amidase (human) that has been O-glycosylated at the residue equivalent to Thr-168 of the amino acid sequence represented by UniProtKB:Q96PD5-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q96PD5-1, Thr-168, MOD:00005~GNO:G29068FM.


name: N-acetylmuramoyl-L-alanine amidase O-glycosylated 8 (human)

description: An N-acetylmuramoyl-L-alanine amidase (human) that has been O-glycosylated at the residue equivalent to Thr-182 of the amino acid sequence represented by UniProtKB:Q96PD5-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q96PD5-1, Thr-182, MOD:00005~GNO:G29068FM.


name: N-acetylmuramoyl-L-alanine amidase O-glycosylated 6 (human)

description: An N-acetylmuramoyl-L-alanine amidase (human) that has been O-glycosylated at the residue equivalent to Thr-181 of the amino acid sequence represented by UniProtKB:Q96PD5-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q96PD5-1, Thr-181, MOD:00005~GNO:G43417UB.


name: N-acetylmuramoyl-L-alanine amidase O-glycosylated 1 (human)

description: An N-acetylmuramoyl-L-alanine amidase (human) that has been O-glycosylated at the residue equivalent to Ser-177 of the amino acid sequence represented by UniProtKB:Q96PD5-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q96PD5-1, Ser-177, MOD:00002~GNO:G43417UB.


name: N-acetylmuramoyl-L-alanine amidase isoform h1 (human)

description: An N-acetylmuramoyl-L-alanine amidase (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96PD5-1.


name: N-acetylmuramoyl-L-alanine amidase O-glycosylated 5 (human)

description: An N-acetylmuramoyl-L-alanine amidase (human) that has been O-glycosylated at the residue equivalent to Thr-181 of the amino acid sequence represented by UniProtKB:Q96PD5-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q96PD5-1, Thr-181, MOD:00005~GNO:G29068FM.


name: N-acetylmuramoyl-L-alanine amidase O-glycosylated 2 (human)

description: An N-acetylmuramoyl-L-alanine amidase (human) that has been O-glycosylated at the residue equivalent to Thr-151 of the amino acid sequence represented by UniProtKB:Q96PD5-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q96PD5-1, Thr-151, MOD:00005~GNO:G43417UB.


name: N-acetylmuramoyl-L-alanine amidase O-glycosylated 10 (human)

description: An N-acetylmuramoyl-L-alanine amidase (human) that has been O-glycosylated at the residue equivalent to Thr-193 of the amino acid sequence represented by UniProtKB:Q96PD5-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q96PD5-1, Thr-193, MOD:00005~GNO:G29068FM.


name: N-acetylmuramoyl-L-alanine amidase O-glycosylated 7 (human)

description: An N-acetylmuramoyl-L-alanine amidase (human) that has been O-glycosylated at the residue equivalent to Thr-181 of the amino acid sequence represented by UniProtKB:Q96PD5-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:Q96PD5-1, Thr-181, MOD:00005~GNO:G53434XO.


name: N-acetylmuramoyl-L-alanine amidase, signal peptide removed form (human)

description: An N-acetylmuramoyl-L-alanine amidase (human) that has had the signal peptide removed. Example: UniProtKB:Q96PD5-1, 22-576.


name: N-acetylmuramoyl-L-alanine amidase N-glycosylated 1 (human)

description: An N-acetylmuramoyl-L-alanine amidase (human) that has been N-glycosylated at the residue equivalent to Asn-367 of the amino acid sequence represented by UniProtKB:Q96PD5-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:Q96PD5-1, Asn-367, MOD:00160~GNO:G00912UN.


name: N-acetylmuramoyl-L-alanine amidase N-glycosylated 2 (human)

description: An N-acetylmuramoyl-L-alanine amidase (human) that has been N-glycosylated at the residue equivalent to Asn-367 of the amino acid sequence represented by UniProtKB:Q96PD5-1, in which the glycan structure is represented by GlyTouCan:G42358LZ. Example: UniProtKB:Q96PD5-1, Asn-367, MOD:00160~GNO:G42358LZ.


name: N-acetylmuramoyl-L-alanine amidase O-glycosylated 4 (human)

description: An N-acetylmuramoyl-L-alanine amidase (human) that has been O-glycosylated at the residue equivalent to Thr-168 of the amino acid sequence represented by UniProtKB:Q96PD5-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q96PD5-1, Thr-168, MOD:00005~GNO:G43417UB.


name: N-acetylmuramoyl-L-alanine amidase O-glycosylated 11 (human)

description: An N-acetylmuramoyl-L-alanine amidase (human) that has been O-glycosylated at the residue equivalent to Thr-193 of the amino acid sequence represented by UniProtKB:Q96PD5-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q96PD5-1, Thr-193, MOD:00005~GNO:G43417UB.


name: lymphocyte antigen 6 complex locus protein G5c isoform h3 (human)

description: A lymphocyte antigen 6 complex locus protein G5c (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5SRR4-3.


homoisocitrate dehydrogenase activity

description: Catalysis of the reaction: NAD+ + 3-carboxy-2-hydroxyadipate = NADH + H+ + CO2 + 2-keto-adipate.


name: regulation of L-leucine import across plasma membrane

description: Any process that modulates the frequency, rate or extent of L-leucine import across plasma membrane.


name: negative regulation of leucine import in response to ammonium ion

description: Any process that decreases the rate, frequency or extent of leucine import as a result of an ammonium ion stimulus. Leucine import is the directed movement of leucine into a cell or organelle.


name: N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase isoform 1 (human)

description: An N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase isoform 1 that is encoded in the genome of human.


growth

description: The increase in size or mass of an entire organism, a part of an organism or a cell.


heart growth

description: The increase in size or mass of the heart.


invasive growth in response to heat

description: The growth of colonies in filamentous chains of cells as a result of an increase in temperature.


name: growth of a germarium-derived egg chamber

description: Growth of the egg chamber between the time it leaves the germarium and the onset of vitellogenesis. During this time both nurse cells and the oocyte undergo developmental changes including nuclear organization and cytoplasmic growth. An example of this is found in Drosophila melanogaster.


glial cell growth

description: Growth of glial cells, non-neuronal cells that provide support and nutrition, maintain homeostasis, form myelin, and participate in signal transmission in the nervous system.


name: filamentous growth of a population of unicellular organisms in response to neutral pH

description: The process in which a group of unicellular organisms grow in a threadlike, filamentous shape in response to a neutral pH (pH close to 7) stimulus.


name: filamentous growth of a population of unicellular organisms in response to starvation

description: The process in which a group of unicellular organisms grow in a threadlike, filamentous shape in response to deprivation of nourishment.


diffuse secondary thickening

description: Lateral growth of the older parts of a stem that occurs when the central parenchyma cells and the not yet fully differentiated fiber cells of the bundle sheaths continue to undergo cell division and expansion for a long period of time, leading to an increase in girth of the stem.


name: cell growth involved in Malpighian tubule morphogenesis

description: The growth of an epithelial cell dependent on cycles of endoreplication, where growth contributes to the shaping of the Malpighian tubule.


floral meristem growth

description: The increase in size or mass of a floral meristem, a population of undifferentiated cells in a plant that gives rise to a flower.


mammary gland cord elongation

description: The process in which the mammary gland sprout grows along its axis.


name: collateral sprouting of intact axon in response to injury

description: The process in which outgrowths develop from the axons of intact undamaged neurons as a result of injury to an axon. The collateral sprouts typically appear from undamaged axons in a tissue which has had part of its nerve supply removed, and they can often innervate successfully any cells that have lost some or all of their original synaptic input.


mammary gland bud elongation

description: The process in which the mammary gland bud grows along its axis.


multidimensional cell growth

description: The process in which a cell irreversibly increases in size in two or three [spatial] dimensions or along two or three axes.


root hair cell tip growth

description: Localized growth of a plant root hair tip by extension of the cell wall.


zygote elongation

description: The process in which the zygote irreversibly increases in size in one dimension after fertilization. An example of such a process is found in Arabidopsis thaliana.


bipolar cell growth

description: The process in which a cell irreversibly increases in size along one axis through simultaneous polarized growth from opposite ends of a cell, resulting in morphogenesis of the cell.


name: invasive growth in response to pheromone

description: The growth of colonies in filamentous chains of cells as a result of a pheromone stimulus.


perineurial glial growth

description: Glial cell growth that occurs in the perineurium, a cell layer that ensheaths projections of peripheral nerves, such as motor axons.


name: post-embryonic cardiac muscle cell growth involved in heart morphogenesis

description: The growth of a cardiac muscle cell during the postembryonic period that contributes to the shaping of the heart.


name: filamentous growth of a population of unicellular organisms in response to heat

description: The process in which a group of unicellular organisms grow in a threadlike, filamentous shape in response to an increase in temperature.


hyphal growth

description: Growth of fungi as threadlike, tubular structures that may contain multiple nuclei and may or may not be divided internally by septa, or cross-walls.


outer ear emergence

description: The growth of the outer ear.


heart capillary growth

description: The increase in heart capillaries that accompanies physiological hypertrophy of cardiac muscle.


name: oocyte growth in germarium-derived egg chamber

description: The increase in volume of an oocyte during the growth phase of the egg chamber, once the egg chamber has left the germarium. An example of this process is found in Drosophila melanogaster.


anisotropic cell growth

description: The process in which a cell irreversibly increases in size in one or more axes, where the growth rate varies according to the direction of growth. Growth may be limited to a particular axis, axes, or to particular locations on the surface of the cell.


name: filamentous growth of a multicellular organism

description: The process in which a multicellular organism grows in a threadlike, filamentous shape.


invasive filamentous growth

description: The growth of colonies in filamentous chains of cells into a substrate.


monopolar cell growth

description: Polarized growth from one end of a cell.


budding cell isotropic bud growth

description: Unlocalized bud growth such that the entire surface of the bud expands evenly, in a cell that reproduces by budding.


name: dorsal trunk growth, open tracheal system

description: Growth of epithelial tubes that originate from pits in an open tracheal system and grow towards each other to meet and form a continuous open tube called the dorsal trunk. The dorsal trunk extends from the anterior spiracle to the posterior spiracle of the larva and forms the main airway of the insect tracheal system.


name: neuron projection extension involved in neuron projection guidance

description: Any neuron projection extension that is involved in neuron projection guidance.


name: growth of unicellular organism as a thread of attached cells

description: A filamentous growth process in which cells remain attached after division and form thread-like filaments that may penetrate into a solid growth medium such as an agar plate, exhibited by unicellular fungi under certain growth conditions.


name: embryonic cardiac muscle cell growth involved in heart morphogenesis

description: The growth of a cardiac muscle cell during the embryonic period, that contributes to the shaping of the heart.


name: filamentous growth of a population of unicellular organisms in response to biotic stimulus

description: The process in which a group of unicellular organisms grow in a threadlike, filamentous shape in response to a biotic (living) stimulus.


neuromast regeneration

description: The regrowth of a neuromast following its loss or destruction.


pseudohyphal growth

description: The process in which cells grow as a chain of physically attached, elongated cells in response to an environmental stimulus or stimuli.


imaginal disc growth

description: The increase in mass of imaginal discs by cell proliferation prior to metamorphosis. Imaginal discs are epithelial infoldings in the larvae of holometabolous insects that develop into adult structures (legs, antennae, wings, etc.) during metamorphosis from larval to adult form.


seed trichome elongation

description: The process in which a seed trichome irreversibly increases in size in one [spatial] dimension or along one axis, resulting in the morphogenesis of the cell.


bud dilation

description: The process in which a branch bud increases radially. A branch bud is the initial area of outgrowth in the formation of a new branch.


name: primary ovarian follicle growth involved in double layer follicle stage

description: Increase in size of primary follicles including oocyte growth and granulosa and/or theca cell proliferation until more than one layer of granulosa cells is present (preantral follicle), as part of the double layer follicle stage of oogenesis.


primary thickening

description: Lateral growth of a plant axis (shoot axis or root) that is an increase in thickness resulting from the activity of a primary thickening meristem.


fin regeneration

description: The regrowth of fin tissue following its loss or destruction.


root hair elongation

description: The process in which the root hair grows longer.


name: skeletal muscle regeneration at neuromuscular junction

description: The regrowth of muscle tissue to repair injured or damaged muscle fibers in the postnatal stage at the neuromuscular junction. Regeneration of neuromuscular junctions occurs in an orderly way and relies on communication between nerve and muscle. Skeletal myofibers regenerate after injury and form neuro-muscular junctions with motor axons similar to normal ones. Regenerating myofibers develop within the basal lamina sheaths (satellite cells) of original myofibers.


secondary thickening

description: Lateral growth of a plant axis (shoot axis or root) that is an increase in thickness resulting from formation of tissue from a secondary thickening meristem.


epithelium regeneration

description: The regrowth of lost or destroyed epithelium.


elongation of arista lateral

description: The increase in length of the aristal laterals. The arista is the terminal segment of the antenna and consists of a central core and a series of lateral extensions.


secondary growth

description: Lateral growth of a plant axis (shoot axis or root) that is an increase in thickness resulting from formation of secondary vascular tissues by the vascular cambium.


name: filamentous growth of a population of unicellular organisms

description: The process in which a group of unicellular organisms grow in a threadlike, filamentous shape.


lateral growth

description: Growth of a plant axis (shoot axis or root) that originates from a lateral meristem.


root meristem growth

description: The increase in size or mass of a root meristem, a population of undifferentiated cells in a plant root which maintains a continuous balance between the production of stem cells and the incorporation of their derivatives into the growth of the root.


name: filamentous growth of a population of unicellular organisms in response to chemical stimulus

description: The process in which a group of unicellular organisms grow in a threadlike, filamentous shape in response to a chemical stimulus.


budding cell bud growth

description: The process in which the bud portion of a cell that reproduces by budding irreversibly increases in size over time by accretion and biosynthetic production of matter similar to that already present.


intramembranous bone growth

description: The increase in size or mass of an intramembranous bone that contributes to the shaping of the bone.


name: dorsal closure, elongation of leading edge cells

description: The change in shape of cells at the dorsal-most (leading) edge of the epidermis from being polygonal to being elongated in the dorsal/ventral axis.


imaginal disc-derived wing expansion

description: The process of expanding or inflating the folded imaginal disc-derived pupal wing, and the adhering of the dorsal and ventral surfaces, to form the mature adult wing.


primary spermatocyte growth

description: The phase of growth and gene expression that male germ cells undergo as they enter the spermatocyte stage. The cells grow in volume and transcribe most of the gene products needed for the morphological events that follow meiosis.


name: formation of growth cone in injured axon

description: The formation of a growth cone in an injured axon.


pollen tube growth

description: Growth of pollen via tip extension of the intine wall.


budding cell apical bud growth

description: Growth at the tip of a bud, in a cell that reproduces by budding.


name: inner ear sensory epithelium regeneration

description: The regrowth of lost or destroyed inner ear sensory epithelia.


elongation of arista core

description: The increase in length of the aristal core. The arista is the terminal segment of the antenna and consists of a central core and a series of lateral extensions.


vegetative meristem growth

description: The increase in size or mass of a vegetative meristem, a population of undifferentiated cells in a plant shoot which maintains a continuous balance between the production of stem cells and the incorporation of their derivatives into lateral organ primordia.


name: radial growth involved in right ventricle morphogenesis

description: The morphogenic growth in which the right ventricle grows along a radial axis.